ATE219491T1 - Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen - Google Patents
Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungenInfo
- Publication number
- ATE219491T1 ATE219491T1 AT98962511T AT98962511T ATE219491T1 AT E219491 T1 ATE219491 T1 AT E219491T1 AT 98962511 T AT98962511 T AT 98962511T AT 98962511 T AT98962511 T AT 98962511T AT E219491 T1 ATE219491 T1 AT E219491T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- acronycin
- derivatives
- production
- pharmaceutical preparations
- Prior art date
Links
- ZTKMNYDOFAYRAK-UHFFFAOYSA-N isoacronycine Natural products CN1C2=CC=CC=C2C(=O)C2=C1C=C1OC(C)(C)C=CC1=C2OC ZTKMNYDOFAYRAK-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- -1 hydroxy, mercapto Chemical class 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004385 trihaloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9716131A FR2772765B1 (fr) | 1997-12-19 | 1997-12-19 | Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR1998/002785 WO1999032491A1 (fr) | 1997-12-19 | 1998-12-18 | Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219491T1 true ATE219491T1 (de) | 2002-07-15 |
Family
ID=9514822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98962511T ATE219491T1 (de) | 1997-12-19 | 1998-12-18 | Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6288073B1 (de) |
| EP (1) | EP1042326B1 (de) |
| JP (1) | JP3825630B2 (de) |
| CN (1) | CN1109686C (de) |
| AT (1) | ATE219491T1 (de) |
| AU (1) | AU738322B2 (de) |
| BR (1) | BR9813756A (de) |
| CA (1) | CA2315909C (de) |
| DE (1) | DE69806189T2 (de) |
| DK (1) | DK1042326T3 (de) |
| ES (1) | ES2179548T3 (de) |
| FR (1) | FR2772765B1 (de) |
| HK (1) | HK1033131A1 (de) |
| HU (1) | HUP0100342A3 (de) |
| NO (1) | NO20003106L (de) |
| NZ (1) | NZ504833A (de) |
| PL (1) | PL192814B1 (de) |
| PT (1) | PT1042326E (de) |
| WO (1) | WO1999032491A1 (de) |
| ZA (1) | ZA9811645B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2795071B1 (fr) * | 1999-06-16 | 2001-07-27 | Adir | Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7056929B2 (en) * | 2001-07-25 | 2006-06-06 | Les Laboratoires Servier | Benzo[b]pyrano[3,2-h]acridin-7-one compounds |
| FR2827864B1 (fr) * | 2001-07-25 | 2005-09-16 | Servier Lab | Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2856687B1 (fr) * | 2003-06-25 | 2005-09-16 | Servier Lab | Nouveaux derives de benzo[a]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR2865734B1 (fr) * | 2004-02-03 | 2006-05-19 | Servier Lab | NOUVAEUX DERIVES DE BENZO[b]CHROMENO-NAPHTHYRIDIN-7-ONE ET DE PYRANO[2'3':7,8]QUINO[2,3-b]QUINOXALIN-7-ONE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
| FR2879600B1 (fr) * | 2004-12-22 | 2007-02-09 | Servier Lab | Nouveaux derives cinnamates de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP4392502B2 (ja) * | 2005-06-10 | 2010-01-06 | 国立大学法人 岡山大学 | 蛍光性アミノ酸誘導体 |
| US11784731B2 (en) * | 2021-03-09 | 2023-10-10 | Apple Inc. | Multi-phase-level signaling to improve data bandwidth over lossy channels |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2716197B1 (fr) * | 1994-02-17 | 1996-04-19 | Adir | Nouveaux analogues de l'acronycine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-12-19 FR FR9716131A patent/FR2772765B1/fr not_active Expired - Fee Related
-
1998
- 1998-12-18 HU HU0100342A patent/HUP0100342A3/hu unknown
- 1998-12-18 ZA ZA9811645A patent/ZA9811645B/xx unknown
- 1998-12-18 WO PCT/FR1998/002785 patent/WO1999032491A1/fr active IP Right Grant
- 1998-12-18 EP EP98962511A patent/EP1042326B1/de not_active Expired - Lifetime
- 1998-12-18 US US09/581,853 patent/US6288073B1/en not_active Expired - Fee Related
- 1998-12-18 DK DK98962511T patent/DK1042326T3/da active
- 1998-12-18 NZ NZ504833A patent/NZ504833A/en unknown
- 1998-12-18 PL PL341281A patent/PL192814B1/pl not_active IP Right Cessation
- 1998-12-18 AT AT98962511T patent/ATE219491T1/de not_active IP Right Cessation
- 1998-12-18 JP JP2000525428A patent/JP3825630B2/ja not_active Expired - Fee Related
- 1998-12-18 CA CA002315909A patent/CA2315909C/fr not_active Expired - Fee Related
- 1998-12-18 CN CN98812425A patent/CN1109686C/zh not_active Expired - Fee Related
- 1998-12-18 DE DE69806189T patent/DE69806189T2/de not_active Expired - Lifetime
- 1998-12-18 PT PT98962511T patent/PT1042326E/pt unknown
- 1998-12-18 BR BR9813756-5A patent/BR9813756A/pt not_active Application Discontinuation
- 1998-12-18 ES ES98962511T patent/ES2179548T3/es not_active Expired - Lifetime
- 1998-12-18 AU AU17663/99A patent/AU738322B2/en not_active Ceased
-
2000
- 2000-06-16 NO NO20003106A patent/NO20003106L/no not_active Application Discontinuation
-
2001
- 2001-06-01 HK HK01103792A patent/HK1033131A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69806189T2 (de) | 2003-02-13 |
| CA2315909A1 (fr) | 1999-07-01 |
| PL192814B1 (pl) | 2006-12-29 |
| ZA9811645B (en) | 1999-06-24 |
| FR2772765B1 (fr) | 2000-03-17 |
| NZ504833A (en) | 2001-11-30 |
| DK1042326T3 (da) | 2002-09-23 |
| HUP0100342A3 (en) | 2003-04-28 |
| CN1109686C (zh) | 2003-05-28 |
| HUP0100342A2 (hu) | 2001-09-28 |
| JP2001526290A (ja) | 2001-12-18 |
| AU1766399A (en) | 1999-07-12 |
| EP1042326B1 (de) | 2002-06-19 |
| DE69806189D1 (de) | 2002-07-25 |
| EP1042326A1 (de) | 2000-10-11 |
| NO20003106L (no) | 2000-08-16 |
| NO20003106D0 (no) | 2000-06-16 |
| ES2179548T3 (es) | 2003-01-16 |
| HK1033131A1 (en) | 2001-08-17 |
| FR2772765A1 (fr) | 1999-06-25 |
| BR9813756A (pt) | 2000-10-03 |
| PT1042326E (pt) | 2002-10-31 |
| CN1282332A (zh) | 2001-01-31 |
| CA2315909C (fr) | 2007-01-02 |
| US6288073B1 (en) | 2001-09-11 |
| AU738322B2 (en) | 2001-09-13 |
| PL341281A1 (en) | 2001-04-09 |
| JP3825630B2 (ja) | 2006-09-27 |
| WO1999032491A1 (fr) | 1999-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9904505D0 (sv) | Novel compounds | |
| NO881940D0 (no) | 4-aminokinolin-derivater og deres anvendelse som legemidler. | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| ATE316083T1 (de) | Adamantanderivate | |
| EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
| ATE219491T1 (de) | Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| BRPI0210746B8 (pt) | derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação | |
| DE69105786D1 (de) | Harnstoffderivate, deren Herstellung sowie diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE60220779D1 (de) | Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
| ATE215941T1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| EA200000532A2 (ru) | НОВЫЕ СОЕДИНЕНИЯ 7-ОКСО-2,3,7,14-ТЕТРАГИДРО-1H-БЕНЗО[b]-ПИРАНО [3,2-h]АКРИДИНКАРБОКСИЛАТА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ | |
| PT1025101E (pt) | Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central | |
| AU579295B2 (en) | New thiazole derivatives, a process for the preparation thereof and pharmaceutical compositions containing them | |
| DK0982308T3 (da) | Derivater af 8H-[2,3-b]pyrrolizin-8-on, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse | |
| BR0201312A (pt) | Compostos de pirimidin-4-ona, processo para sua preparação e composições farmacêuticas contendo os referidos | |
| ATE228359T1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| DE69824410D1 (en) | Antithrombosemittel | |
| KR970702238A (ko) | 0-아실-4-페닐-사이클로헥산올 및 이의 염, 이를 함유하는 약제, 이의 용도 및 이의 제조방법(0-Acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them) | |
| SE9704835D0 (sv) | New compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |